CD8A and cancer: Related studies have proved that immunotherapy induces IFN-γ increasing release by activation of CD8+ T cells, downregulates the expression of the xc-subunit of the glutamate-cystine reverse transport system and weakens the uptake of cystine by cancer cells, thereby promoting cancer cell death [32].